These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17383006)

  • 1. Janus faces of microglia in multiple sclerosis.
    Sanders P; De Keyser J
    Brain Res Rev; 2007 Jun; 54(2):274-85. PubMed ID: 17383006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G; Banati R
    Brain Res Brain Res Rev; 2004 Nov; 46(3):261-81. PubMed ID: 15571769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system.
    Kawanokuchi J; Mizuno T; Kato H; Mitsuma N; Suzumura A
    Neuropharmacology; 2004 Apr; 46(5):734-42. PubMed ID: 14996551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia-derived macrophages in early multiple sclerosis plaques.
    Li H; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and multiple sclerosis.
    Jack C; Ruffini F; Bar-Or A; Antel JP
    J Neurosci Res; 2005 Aug; 81(3):363-73. PubMed ID: 15948188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and functions of IL-17 in microglia.
    Kawanokuchi J; Shimizu K; Nitta A; Yamada K; Mizuno T; Takeuchi H; Suzumura A
    J Neuroimmunol; 2008 Feb; 194(1-2):54-61. PubMed ID: 18164424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microglia in the pathogenesis of osmotic-induced demyelination.
    Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
    Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta is neuroprotective against the toxicity induced by activated microglia.
    Jin S; Kawanokuchi J; Mizuno T; Wang J; Sonobe Y; Takeuchi H; Suzumura A
    Brain Res; 2007 Nov; 1179():140-6. PubMed ID: 17905201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
    Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia.
    Muzio L; Martino G; Furlan R
    J Neuroimmunol; 2007 Nov; 191(1-2):39-44. PubMed ID: 17936915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the histopathology of MS?
    Kuhlmann T; Goldschmidt T; Antel J; Wegner C; König F; Metz I; Brück W
    J Neurol Sci; 2009 Nov; 286(1-2):86-91. PubMed ID: 19674757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microglia--biology and relevance to disease].
    Wirenfeldt M; Ladeby R; Dalmau I; Banati RB; Finsen B
    Ugeskr Laeger; 2005 Aug; 167(33):3025-30. PubMed ID: 16109243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
    Mirshafiey A; Jadidi-Niaragh F
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):543-54. PubMed ID: 20233088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE; Nichols PP; Bates D; Turnbull DM
    Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.
    Satoh J; Obayashi S; Misawa T; Tabunoki H; Yamamura T; Arima K; Konno H
    Neuropathology; 2008 Dec; 28(6):561-76. PubMed ID: 18410276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.